Schedule 13D ownership disclosure

Ironwood Pharmaceuticals Inc

Class A Common Stock, $0.001 par value · CUSIP: 46333X108

Event date: 2026-03-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sarissa Capital Management LPReported CIK 0001577524

    Shares: 9,188,635 · Class: 5.6%

  • Alexander J. Denner

    Shares: 9,444,944 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-26-000333
Form type
SCHEDULE 13D/A
Filer
IRONWOOD PHARMACEUTICALS INC
CIK
CIK 1446847
Filed
Mar 19, 2026
Reporting period
Mar 17, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub